83-3872-07 Biotinylated SARS-CoV-2 Spike NTD Protein, His,Avitag (B.1.1.529/Omicron) (MALS verified) 25ug SPD-C82H4-25ug

※お見積書はカートで印刷できます

冷凍

特徴

  • 背景
  • It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor.
  • The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2.
  • S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor.
  • S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
  • 特徴
  • This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag).
  • The protein has a calculated MW of 36.3 kDa.
  • The protein migrates as 46-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

仕様

  • 容量:25ug
  • Source:Biotinylated SARS-CoV-2 Spike NTD, His,Avitag (B.1.1.529/Omicron) (SPD-C82H4) is expressed from human 293 cells (HEK293). It contains AA Ser 13 - Leu 303 (Accession # QHD43416.1 (A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE)). The spike mutations are identified on the SARS-CoV-2 Omicron variant (Pango lineage: B.1.1.529; GISAID clade: GR/484A; Nextstrain clade: 21K).
  • Species Reactivity:SARS-CoV-2
  • Host:HEK293
  • Tag:C-10×His & C-Avi
  • Exp Region:Ser 13 - Leu 303
  • Format:Powder
  • Conjugate:Biotin-labeled
  • Protein ID:QHD43416.1 (A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE)
  • Endotoxin:1.0 EU per μg
  • Purity:95%
  • Buffer:PBS, pH7.4
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
83-3872-07
型番
SPD-C82H4-25ug
入り数
1個
標準価格
86,520円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る